TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.